当前位置:首页 >财报库 > 报告详情

拜耳集团Bayer(BAYZF)2025年年度报告「OTC」(英文版)(430页).pdf

上传人: 1****1 编号:1184319 2026-04-08 430页 8.39MB

下载:

1、Annual Report 2025 Bayer Annual Report 2025 Five-Year Summary 2Five-Year Summary million 2021 2022 2023 2024 2025 Bayer Group financial KPIs Sales 44,081 50,739 47,637 46,606 45,575 EBITDA1 6,409 13,515 10,632 8,712 1,708 EBITDA before special items1 11,179 13,513 11,706 10,123 9,669 EBITDA margin b

2、efore special items1 25.4%26.6%24.6%21.7%21.2%EBIT1 3,353 7,012 612(71)(1,077)EBIT before special items1 7,295 9,257 7,589 5,436 5,108 Net income(from continuing and discontinued operations)1,000 4,150(2,941)(2,552)(3,620)Earnings per share(from continuing and discontinued operations)()1 1.02 4.22(2

3、.99)(2.60)(3.68)Core earnings per share(from continuing operations)()1 6.51 7.94 6.39 5.05 4.91 Free cash flow 1,415 3,111 1,311 3,107 2,084 Net financial debt 33,137 31,809 34,498 32,626 29,843 Return on capital employed(ROCE)(%)3.8 7.7 0.7 0.1 1.4 Research and development expenses2 5,412 6,572 5,3

4、71 6,209 5,769 Dividend per share()2.00 2.40 0.11 0.11 0.11 Bayer Group nonfinancial KPIs3 Number of smallholder farmers in low-and middle-income countries supported by products,services and partnerships(million)49 52 53 52 53 Number of women in low-and middle-income countries who have their need fo

5、r modern contraception satisfied due to interventions supported by Bayer(million)41 44 46 51 68 Number of people in underserved4 communities whose self-care is supported by interventions from Bayer(million)46 49 51 53 82 Scope 1 and 2 greenhouse gas emissions(million metric tons)3.17 3.03 3.00 2.96

6、2.79 Scope 3 greenhouse gas emissions from relevant categories(million metric tons)5 9.06 10.32 9.72 8.82 9.10 Offsetting of remaining Scope 1 and 2 greenhouse gas emissions(million metric tons)0.30 0.45 0.60 0.71 0.91 Employees Number of employees6(Dec.31)99,637 101,369 99,723 92,815 88,078 Personn

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **财务表现**:2025年集团销售额456亿欧元,EBITDA(特殊项目前)97亿欧元,核心每股收益4.91欧元,净现金流21亿欧元,净金融债务降至298亿欧元。 2. **业务动态**: - **制药**:Nubeqa™和Kerendia™增长强劲,新药Beyonttra™和Lynkuet™上市。 - **作物科学**:推出Plenexos™杀虫剂和Preceon™玉米系统,计划关闭法兰克福工厂。 - **消费者健康**:受美中市场挑战影响,销售增长放缓但盈利达标。 3. **诉讼进展**:孟山都与原告律所达成草甘膦诉讼和解,PCB诉讼部分案件获解决。 4. **运营改革**:实施“动态共享所有权”(DSO)模式,减少管理层级,加速决策。 5. **可持续发展**:支持5300万小农,6800万女性获得现代避孕服务,82万弱势群体获得自我护理支持。
**Bayer的转型成效如何?** **诉讼问题如何影响Bayer?** **创新战略有何新进展?**
客服
商务合作
小程序
服务号
折叠